Article

Study favors centering ablation profile over vertex

Centering the corneal ablation profile over the corneal vertex when treating hyperopia using an excimer laser platform (Schwind Esiris, Schwind eye-tech-solutions) results in better visual outcomes compared with ablations that were centered over the pupil centroid.

Key Points

Dr. El-Kateb and colleagues conducted a study to evaluate the visual effect of ablations centered over the corneal vertex in patients with hyperopia compared with ablations centered over the pupil centroid. The rationale for the study was to determine a difference in approaches because, Dr. El-Kateb said, all excimer laser ablations are centered on the pupil centroid.

Determining center of ablation

The method used in this study to determine the center of the ablation on topography was the circle difference, in which a transparency with multiple concentric circles is placed atop the difference map and a cursor is placed in the center, he said.

Analysis of the safety data indicated that centering the ablation over the corneal vertex resulted in a more beneficial visual outcome.

"Excellent centration of hyperopic correction is possible in eyes with a positive angle kappa when the ablation is centered over the corneal vertex. Further studies are needed with a larger number of patients and longer follow-up periods to confirm our results," he concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.